Status:
COMPLETED
Study of Red Blood Cell Transfusion Triggers in Patients Undergoing Hematopoietic Stem Cell Transplantation
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
Canadian Blood Services
Canadian Institutes of Health Research (CIHR)
Conditions:
Hematologic Malignancies
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Transfusion of red blood cells (RBCs) is important for the care of patients undergoing stem cell transplantation. Stem cell transplants are used to treat blood cancers and bone marrow disorders. This ...
Detailed Description
1. Males or females aged 18 years or older who are undergoing either an autologous or allogeneic HSCT. 2. The indications for HSCT may include, but not limited to the following diseases : 1. Acute...
Eligibility Criteria
Inclusion
- Patients are aged 16-70 undergoing either an autologous or allogeneic HSCT for any hematologic malignancy
Exclusion
- Pregnant or lactating at the time of enrollment
- Already received red cell transfusion after HSCT but prior to enrollment
- Unable/unwilling to provide informed consent.
- Patients receiving HSCT for non-malignancy
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01237639
Start Date
March 1 2011
End Date
October 1 2016
Last Update
October 12 2016
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Health Sciences Centre
Hamilton, Ontario, Canada, L8N 3Z5
2
London Health Sciences Centre, University Hospital
London, Ontario, Canada, N6A 5A5
3
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6
4
Saskatchewan Cancer Centre
Saskatoon, Saskatchewan, Canada, S7N 4H4